PET-CT and Hybrid Imaging

Overview

PET-CT (Positron Emission Tomography–Computed Tomography) and other hybrid imaging systems combine functional and structural imaging in a single examination. PET visualizes metabolic and physiological activity, while CT provides detailed anatomical information. Together, they enable more accurate detection, localization, and monitoring of diseases.

Hybrid imaging has transformed medical diagnosis by allowing observation of disease processes at both molecular and structural levels. In oncology, PET-CT locates tumors, evaluates their spread, monitors treatment response, and detects recurrence. In neurology, it assesses brain metabolism and aids in diagnosing conditions such as dementia or seizure disorders. In cardiology, PET-CT evaluates heart muscle viability and blood flow.

Emerging technologies like PET-MRI offer higher soft-tissue contrast and lower radiation exposure, particularly beneficial in neurological and pediatric imaging. Continued advancements in hybrid imaging support precise diagnosis, personalized treatment planning, and improved patient outcomes.

Sub-Tracks of PET-CT and Hybrid Imaging

1. Molecular Imaging – Visualizing cellular and molecular processes to understand disease mechanisms.
2. Nuclear Medicine Techniques – Utilizing radioactive tracers to study organ function and physiology.
3. PET Radiotracers – Development and use of radiopharmaceuticals, including FDG and novel tracers.
4. FDG-PET Applications – Imaging glucose metabolism in oncology, infection, and inflammation.
5. PET-MRI Technology – Hybrid systems combining PET functional data with high-contrast MRI images.
6. Image Fusion Methods – Techniques to integrate PET and CT/MRI data for precise localization.
7. Radiopharmaceutical Development – Creating new tracers for specific molecular targets.
8. Oncology PET – Tumor detection, staging, therapy monitoring, and recurrence assessment.
9. Cardiac PET – Evaluating myocardial perfusion, viability, and metabolism.
10. Neurological PET – Assessing brain function, neurodegeneration, and seizure disorders.
11. Quantitative Imaging – Measuring metabolic activity, uptake values, and other quantitative metrics.
12. Hybrid Scanner Advancements – Innovations in hardware and software improving hybrid imaging performance.